Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance

Melanoma is a highly malignant skin cancer with high propensity to metastasize and develop drug resistance, making it a difficult cancer to treat. Current therapies targeting BRAF (V600) mutations are initially effective, but eventually tumors overcome drug sensitivity and reoccur. This process is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Reger de Moura, Coralie, Prunotto, Marco, Sohail, Anjum, Battistella, Maxime, Jouenne, Fanelie, Marbach, Daniel, Lebbé, Celeste, Fridman, Rafael, Mourah, Samia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516126/
https://www.ncbi.nlm.nih.gov/pubmed/33014862
http://dx.doi.org/10.3389/fonc.2020.01748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516126/
https://www.ncbi.nlm.nih.gov/pubmed/33014862
http://dx.doi.org/10.3389/fonc.2020.01748

Ejemplares similares